Cm-24 drug page Clinical trials

Trials with Cm-24

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
3Countries
106Planned patients

Showing 1–2 of 2

A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
Finished Phase 1 79 patients NCT04731467

This is an open-label, multicenter, multi-dose escalation and dose expansion study in subjects with selected advanced solid tumors (Part A) and advanced metastatic pancreatic cancer (Parts C \& D) to evaluate the safety and tolerability of…

United States, Israel, Spain Mar 2021 – Sept 2024 Interventional
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
Finished Phase 1 27 patients NCT02346955

The purpose of this study is to evaluate the safety and tolerability of humanized IgG4 (kappa) isotype monoclonal antibody against CEACAM1 (CM-24 \[MK-6018\]), administered intravenously as monotherapy and in combination with Pembrolizumab…

United States, Israel Feb 2015 – Feb 2017 Interventional
Combined with: Pembrolizumab